Dr. Hugh Hetherington Publishes New Study in Clinical, Cosmetic and Investigational Dermatology Journal

Injection Technologies, a dynamic early-stage medical device company developing a revolutionary method for automating fluid delivery, is pleased to announce the recent publication of Facial Fat Grafting With a Prototype Injection Control Device in the journal Clinical, Cosmetic and Investigational... - October 22, 2013 - Jon Block Group

AveXis-BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Children's Hospital and The Ohio State University

BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio. The license... - October 21, 2013 - AveXis Inc.

Creative Biomart Releases New Products in the Middle of Oct.

In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart

Microfluidics Startup NanoCellect Adds Strategic Advisors and Nabs Another $700K from the NIH

NanoCellect, (previously called NanoSort) aims to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more affordable and easier to use. Spunout from UCSD in late 2009, NanoCellect has now raised over $3.3M including a new $700K grant to continue developing... - October 19, 2013 - NanoCellect

AveXis BioLife Announce The Research Institute at Nationwide Children’s Hospital Received Fast Track Status for Spinal Muscular Atrophy Treatment

AveXis and BioLife, synthetic biology platform companies, today announced that The Research Institute at Nationwide Children’s Hospital received Fast Track designation from the U.S. Food and Drug Administration for its scAAV9.CB.SMN gene therapy product for the treatment of spinal muscular... - October 18, 2013 - AveXis Inc.

The Colorado BioScience Association Celebrates 10 Years of Supporting Bioscience in Colorado at the Annual Awards Dinner

The Colorado BioScience Association (CBSA) is celebrating its 10th Anniversary with special honors during its Annual Awards Dinner at the Denver Marriott City Center. This year’s event will feature three very special honors given only for the 10th anniversary, including the Pioneering Award, Founders Award and Visionary Award. - October 16, 2013 - Colorado BioScience Association

Good News for Drug Delivery Researchers: AbboMax, Inc. Offers a Portfolio of Innovative Liposome Reagents

Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer. The liposomes can be filled with different substances and used as vehicles for drug or nutrient delivery. AbboMax offers various innovative liposome reagents with a large number of lipid compositions to support the needs of research organizations involved in liposome drug delivery. - October 16, 2013 - AbboMax, Inc.

Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate (ADC) Levels

Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. - October 12, 2013 - Epitope Diagnostics, Inc.

Dr. Marehalli Prasad to Deliver Prestigious Memorial Lecture at 2013 Acoustics Conference in India

Distinguished lecture to discuss the significance of acoustical design in religious spaces. - October 11, 2013 - Stevens Institute of Technology

Dr. Hongbin Li Awarded 2013 IEEE Jack Neubauer Award for Cognitive Radio Innovation

Groundbreaking cognitive radio research advances technology for wireless network access. - October 10, 2013 - Stevens Institute of Technology

Mini-Gastric Bypass Performed with SPIDER® Surgical System

Internationally respected surgeon Dr. Michel Gagner completed procedure using fewer incisions. - October 10, 2013 - TransEnterix

Dr. Darinka Dentcheva Awarded NSF Grant to Aid High-Stakes Decision Making

Mathematical models quantify risk over time as they predict future states of real-world systems. - October 04, 2013 - Stevens Institute of Technology

MD Stem Cells Indicates Government Shutdown Will Not Impact SCOTS Eye Stem Cell Treatment Study

MD Stem Cells sees no immediate effect on the SCOTS eye stem cell trial but is monitoring NIH throughout the government shutdown. - October 03, 2013 - MD Stem Cells

HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2

Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding

The Changing Environment for Pharma and Medtech Companies in Europe

SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd

Your Stem Cell Success Stories Can Help Bring Hope to Others

HopeCell.org Founders Invite Stem Cell Patients to Share Their Experiences and Successes - September 29, 2013 - HopeCell

Pipette.com Announces Promotional T-Shirt and Other Specials for Neuroscience 2013

Pipette.com, distributor of liquid handling products, is attending Neuroscience 2013. They will be answering questions, demoing products, and raffling promotional t-shirts in Booth #3331. - September 28, 2013 - Pipette.com

Phase Focus Announces the Delivery and Installation of a Lens Profiler Instrument to the Brien Holden Vision Institute in Sydney, Australia

Phase Focus Limited is pleased to announce the successful delivery and installation of a Lens Profiler Instrument to the Brien Holden Vision Institute in Sydney, Australia; one of the world’s leading applied vision correction research institutes. This innovative instrument uses the Phase... - September 28, 2013 - Phase Focus

Multichannel Pipettes Promotion Now Available at Pipette.com

Pipette.com, major distributor of liquid handling products, has announced their extension of promotions on multichannel pipettes. The promotions will help labs increase productivity. - September 26, 2013 - Pipette.com

Dr. Len Imas Awarded ONR Grant to Investigate Applicability of Probabalistic Computational Fluid Dynamic Methods to Problems Involving Cavitation

Researcher develops more realistic simulation of flows around partially-cavitating hydrofoils - September 25, 2013 - Stevens Institute of Technology

Stevens Researcher Awarded ONR Grant to Advance Understanding of Planing Hull Hydrodynamics and Design

Dr. Len Imas applies computational modeling to investigate hydrodynamics of “ultra-deep vee” hulls. - September 25, 2013 - Stevens Institute of Technology

Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory

After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart

Colorado BioScience Association Partners with Two of the State’s Economic Development Entities to Promote Colorado’s Strengths at AdvaMed 2013  

Representatives from the Colorado BioScience Association, the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostic sectors during the 2013 AdvaMed: The MedTech Conference in Washington D.C., September 23-25.   - September 20, 2013 - Colorado BioScience Association

SignaBlok Achieves Key in Vivo Proof of Concept for Treatment of Cancer and Sepsis

Novel First-in-Class Peptide Inhibitor of TREM-1 Modulates the Inflammatory Response and Shows Promise for Treatment of Cancer and Sepsis - September 18, 2013 - SignaBlok, Inc.

Dr. Eui-Hyeok Yang Commences Term as ASME MEMS Division Chair

MEMS expert recognized for commitment to innovation through collaboration and education. - September 18, 2013 - Stevens Institute of Technology

30+ Life Science Investors & Strategic Partners Convene in Denver This Week for 2013 Rocky Mountain Life Science Investor & Partnering Conference

More than 30 leading investors and strategic partners from across the country will come to Denver to connect and invest in the region's emerging life science companies at the 2013 Rocky Mountain Life Science Investor & Partnering Conference. Spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — the conference opens with a reception at the Colorado Governor’s Mansion September 18th. - September 16, 2013 - Colorado BioScience Association

AveXis Inc. Names Director, Scientific and Corporate Affairs

AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Mindy Du as the company’s new Director of Scientific and Corporate Affairs. This is an essential position within the company, as AveXis is focused on research/development of leading-edge technology for disease... - September 13, 2013 - AveXis Inc.

NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development

The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita

Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)

Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)

Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics

Collaborators Awarded NSF Grant for More Efficient Wireless Networks

Researchers aim to end the scarcity of wireless spectrum with dynamic and efficient access. - September 11, 2013 - Stevens Institute of Technology

Meditech Global, Inc. to Attend the 9th World Meeting on Pharmaceutics, Bio-Pharmaceutics and Pharmaceutical Technology

Meditech Global, Inc., a healthcare and Life Science venture capital company, is pleased to announce they will be attending the 9th World Meeting on Pharmaceutics, Bio-pharmaceutics and Pharmaceutical Technology. - September 10, 2013 - Meditech Global Inc

Bioo Scientific Honored with Technology Award

Bioo Scientific, an Austin, Texas-based biotechnology company founded in 2003, that is focused on developing and marketing life science research products, was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards, held... - September 08, 2013 - Bioo Scientific

Stevens Researcher Awarded Collaborative NSF Grant to Understand Bimetallic Nanoparticles for Renewable Energy

Innovative research targets fundamentals of biomass conversion into fuels and chemicals over catalytic bimetallic nanoparticles. - September 06, 2013 - Stevens Institute of Technology

SafeStitch Medical Completes Merger with TransEnterix

$30 Million Financing Raised from Existing TransEnterix and SafeStitch Medical Stockholders, Combined Company to be Renamed TransEnterix. - September 06, 2013 - TransEnterix

Leading CEOs Keynote 2013 Rocky Mountain Life Science Investor & Partnering Conference in Denver

CEOs from Clovis Oncology and Array BioPharma will keynote the opening breakfast at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) September 19 at The Ritz-Carlton, Denver. In addition, the conference luncheon will feature Jeff Calcagno, M.D., Principal, Venture Investments, Johnson & Johnson Development Corporation. - September 03, 2013 - Colorado BioScience Association

SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event

SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd

Pipette.com Has Extended Their Summer Promotions on Pipettes to Help Alleviate Sequestration Challenges

Pipette.com, major liquid handling products distributor, is extending their summer promotions on pipettes. The extension of these promotions will benefit labs dealing with budget cuts and looking to save money. - August 29, 2013 - Pipette.com

Stevens Researcher Awarded NIST Grant to Standardize Depth-Resolving Optical Imaging

Emerging technologies could help detect numerous diseases at earlier stages of development - August 28, 2013 - Stevens Institute of Technology

CHI Interviews Janet L. Lathey, Ph.D of Emergent BioSolutions on Optimizing Bioassays for Biologics

Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, new tools and strategies that researchers are using to combat it, and... - August 26, 2013 - Cambridge Healthtech Institute

Stem Cell Research and Therapy Website Provides Hope for Future Treatment

New Website Launched to Connect Patients and Inspire Hope of a Healthy Future Through Stem Cells - August 25, 2013 - HopeCell

Bioo Scientific Launches Test Strips for Ractopamine and Clenbuterol Screening at AOAC 2013

Bioo Scientific will showcase new AuroFlow™ Ractopamine Strip Test Kits and AuroFlow™ RC Combo Strip Test Kits for the detection of ractopamine and clenbuterol in swine urine, at booth #118 of the 127th AOAC Annual Meeting, August 25-28 in Chicago, IL. The AuroFlow™ Ractopamine... - August 25, 2013 - Bioo Scientific

Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions

The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart

Pipette.com Has Announced Their Universal Pipette Filter Tip Promotion to Benefit Labs Dealing with Budget Cuts

Pipette.com, leading liquid handling product distributor, announces their universal pipette filter tip promotion. This promotion allows labs impacted by sequestration to extend their plastic consumable budget. - August 23, 2013 - Pipette.com

Zenalux Research Partnership with Roswell Park Cancer Institute Deploys Zenascope™ PC1 in Interstitial Photodynamic Therapy

Zenalux Biomedical, Inc., a biomedical diagnostics company, is now collaborating with Roswell Park Cancer Institute through the Zenalux Research Partnership program. The partnership has been formed to enable Roswell to use the Zenascope™ PC1 for interstitial photodynamic therapy. The PC1 will... - August 22, 2013 - Zenalux Biomedical, Inc.

AveXis Inc. Names Director of Clinical Operations and Research

AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Minna Du as the company’s Director of Clinical Operations and Research. This is a critical position within the company, as AveXis is focused on research/development of technology for disease treatment. - August 21, 2013 - AveXis Inc.

Stevens Research Honored in Highlights 2012 Issue of Nanotechnology Journal

Innovation in battery technology could drastically cut charge-time for mobile devices - August 21, 2013 - Stevens Institute of Technology

AbboMax, Inc. Announces the Availability of a Portfolio of 23 Stem Cell Research Antibodies

Stem cell research is one of the most fascinating areas of modern biology. AbboMax offers 23 antibodies for stem cell research. Among them antibodies for FOX (Forkhead box) proteins, a family of transcription factors that play important roles in regulating the expression of genes involved in cell growth, proliferation, differentiation, and metabolism. Selected anti- FOXA-1,2,3 and Anti- FOXP-1,2,3 antibodies are validated for use in Western blot. - August 20, 2013 - AbboMax, Inc.

Creative Biomart Releases New Antibody Products—Nanobodies

Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart

MoBiTec GmbH, Germany, is Offering SURE Gene Expression System for Bacillus Subtilis, Regulated by Subtilin

A system for SUbtilin-Regulated gene Expression (SURE) in Bacillus subtilis is offered. Subtilin is a small peptide antibiotic produced by Bacillus subtilis. The SURE system provides an alternative to, e.g., IPTG or xylose inducible systems. - August 17, 2013 - MoBiTec GmbH

Genohub Launches Next Generation Sequencing Marketplace

Genohub announced the launch of their online market for next generation sequencing services today. - August 17, 2013 - Genohub

Press Releases 1,451 - 1,500 of 3,256